December 20, 2024- Baxter reported on December 19 that the company is making continued strong progress at its North Cove facility, having now restarted 8 of the 10 manufacturing lines at the site, which represent ~85% of the site’s total pre-hurricane capacity. While Baxter states that the recently restarted lines will require time to ramp up, some of the earlier lines to restart are operating near pre-hurricane levels. The company currently expects to be producing at pre-hurricane levels across the plant early in the first quarter of 2025.
Baxter also communicated additional allocation increases for several IV product groups to U.S. customers and distributors, effective in phases beginning Dec. 16 and Dec. 30.
Baxter noted in the company’s December 19 update that it will take some time for product to flow through the distribution channels. To that end, they currently expect that North Cove’s recovery to full production will translate to removal of allocations for the related product groups during the first quarter of 2025.